Tarsus Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Tarsus Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $96.13. The average 1-year stock price forecast is 21.22% higher than the current stock price, while the lowest is $84 (+5.93%) and the highest is $105 (+32.41%).

Price Target: $96.13 (+21.22%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$84	$96.13	$99.5	$105
Change	+5.93%	+21.22%	+25.47%	+32.41%

Analyst Ratings

The average analyst rating for Tarsus Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Jul '26	Aug '26	Sep '26
Strong Buy	8	8	8	8	7	8
Buy	1	1	1	1	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	7	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dennis Ding Jefferies	Jefferies	Buy Reiterates $105	Buy	Reiterates	$105	+32.41%	Sep 8, 2026
Lachlan Hanbury Brown William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Aug 12, 2026
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Buy Maintains $100	Buy	Maintains	$100	+26.10%	Aug 12, 2026
Mazahir Alimohamed Oppenheimer	Oppenheimer	Buy Reiterates $97 → $100	Buy	Reiterates	$97 → $100	+26.10%	Aug 12, 2026
Francois Brisebois LifeSci Capital	LifeSci Capital	Buy Reiterates $104	Buy	Reiterates	$104	+31.15%	Aug 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

714.85M

from 451.36M

58.38%

from 451.36M

Revenue Next Year

910.27M

from 714.85M

27.34%

from 714.85M

EPS This Year

-2.10

from -1.59

EPS Next Year

2.42

from -2.10

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	57.03M	25.82M	17.45M	182.95M	451.36M	714.85M
Revenue Growth	-	-54.73%	-32.42%	948.62%	146.71%	58.38%
Operating Income	-12.16M	-62.71M	-143.16M	-120.57M	-70.97M	-100.37M
Net Income	-13.83M	-62.09M	-135.89M	-115.55M	-66.42M	-95.74M
EPS	-	-	-	-	-1.59	-2.10
Free Cash Flow	4.74M	-27.35M	-74.49M	-50.48M	-164.00K	-114.61M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	722.9M
Avg	714.9M
Low	706.5M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	60.2%
Avg	58.4%
Low	56.5%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.63
Avg	-2.10
Low	-2.33

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-